Hidradenitis Suppurativa — MCQs
Which of the following are treatment options for acne vulgaris?
Which of the following best describes the current understanding of rosacea pathogenesis?
A patient with typical cutaneous lesions, slightly elevated red or purple macules often covered by gray or yellow adherent scales. Forceful removal of the scale reveals numerous ‘carpet tack’ extensions. The lesion is:
Statement 1 - A 59-year-old patient presents with flaccid bullae. Histopathology shows a suprabasal acantholytic split. Statement 2 - The row of tombstones appearance is diagnostic of Pemphigus vulgaris.
A 25-year-old female presents with the following lesions in the axilla, as shown by the arrow:
What is the latest retinoid drug used in acne?
What are the treatment options for acne vulgaris?
An 18-year-old girl presents with predominantly comedonal acne. What is the first-line treatment?
What causes a potato tumor?
A teenage girl presented in OPD with moderate acne and history of irregular menses. What treatment will you give?
Hidradenitis Suppurativa Indian Medical PG Practice Questions and MCQs
Question 1: Which of the following are treatment options for acne vulgaris?
- A. Isotretinoin
- B. All of the options (Correct Answer)
- C. Topical erythromycin
- D. Oral Minocycline
Explanation: ***All of the options*** - All listed options (Isotretinoin, Topical erythromycin, and Oral Minocycline) are well-established and commonly used **treatment options for acne vulgaris**, depending on the severity and type of acne. - The choice of treatment often follows a stepped approach, starting with topical agents for mild to moderate acne and progressing to oral medications like antibiotics or isotretinoin for more severe or resistant cases. *Isotretinoin* - **Isotretinoin** is a powerful oral retinoid primarily used for **severe, recalcitrant nodular acne** that has not responded to other treatments. - It works by reducing sebum production, follicular hyperkeratinization, inflammation, and the growth of *P. acnes*. *Topical erythromycin* - **Topical erythromycin** is an **antibiotic** used to treat mild to moderate inflammatory acne by reducing the growth of *Cutibacterium acnes* (formerly *Propionibacterium acnes*) and decreasing inflammation. - It is often combined with other topical agents like benzoyl peroxide to minimize the development of **antibiotic resistance**. *Oral Minocycline* - **Oral minocycline** is a **tetracycline antibiotic** used for moderate to severe inflammatory acne. - It reduces bacterial populations on the skin and exhibits **anti-inflammatory properties**, making it effective for widespread or deeper lesions.
Question 2: Which of the following best describes the current understanding of rosacea pathogenesis?
- A. Primarily caused by increased sebum production similar to acne vulgaris
- B. Solely due to increased reactivity of cutaneous blood vessels to vasodilators
- C. Multifactorial etiology with no single definitive cause established (Correct Answer)
- D. Results from bacterial infection affecting the entire face and back
Explanation: ***Multifactorial etiology with no single definitive cause established*** - Rosacea is understood to arise from complex interactions between **genetic predisposition**, **environmental triggers**, **immune dysregulation**, and **neurovascular dysfunction**. - No single factor fully explains its development; rather, it's a **synergistic interplay** of multiple pathways. *Primarily caused by increased sebum production similar to acne vulgaris* - While sebaceous glands can be affected in phymatous rosacea, **increased sebum production** is the primary driver of **acne vulgaris**, not rosacea. - Rosacea is fundamentally a disorder of **neurovascular and immune dysregulation**, not primarily of follicular obstruction or sebum overproduction. *Solely due to increased reactivity of cutaneous blood vessels to vasodilators* - While **vascular dysfunction** and increased reactivity to vasodilators are significant components of rosacea, they are not the sole causative factor. - **Inflammation**, genetic factors, and immune system involvement also play crucial roles. *Results from bacterial infection affecting the entire face and back* - Rosacea is not solely caused by a **bacterial infection**, although the **skin microbiome** (e.g., *Demodex mites*, *Bacillus oleronius*) may contribute to inflammation in some cases. - Unlike conditions like **acne**, which is linked to *Cutibacterium acnes*, rosacea is not considered a primary bacterial infection.
Question 3: A patient with typical cutaneous lesions, slightly elevated red or purple macules often covered by gray or yellow adherent scales. Forceful removal of the scale reveals numerous ‘carpet tack’ extensions. The lesion is:
- A. Scleroderma
- B. DLE (Correct Answer)
- C. SLE
- D. Lichen planus
Explanation: ***DLE*** - **Discoid lupus erythematosus (DLE)** lesions are characterized by **erythematous-to-violaceous plaques**, often with **follicular plugging** and a **firmly adherent scale**. - The "carpet tack" sign refers to the painful, prickly projections observed on the undersurface of a removed scale, indicating keratinous plugs within hair follicles, which is highly suggestive of DLE. *Scleroderma* - **Scleroderma** involves **fibrosis** of the skin, leading to hardening and thickening, often preceded by Raynaud's phenomenon. - It does not typically present with elevated red or purple macules with adherent scales or the "carpet tack" sign. *SLE* - **Systemic lupus erythematosus (SLE)** is a multi-system autoimmune disease that can have cutaneous manifestations, but these are often more diffuse (**malar rash**, photosensitivity) or non-scarring. - While DLE can occur in SLE patients, the description specifically points to the localized, scarring nature of DLE rather than the systemic features of SLE itself. *Lichen planus* - **Lichen planus** typically presents with **pruritic, polygonal, planar, purple papules and plaques** (the "6 Ps"). - While it can have scaling, it does not exhibit the "carpet tack" sign or the distinct follicular plugging seen in DLE.
Question 4: Statement 1 - A 59-year-old patient presents with flaccid bullae. Histopathology shows a suprabasal acantholytic split. Statement 2 - The row of tombstones appearance is diagnostic of Pemphigus vulgaris.
- A. Statements 1 & 2 are correct, 2 is not explaining 1 (Correct Answer)
- B. Statements 1 and 2 are correct and 2 is the correct explanation for 1
- C. Statements 1 and 2 are incorrect
- D. Statement 1 is incorrect
Explanation: ***Correct: Statements 1 & 2 are correct, 2 is not explaining 1*** **Analysis of Statement 1:** - A 59-year-old patient with **flaccid bullae** and **suprabasal acantholytic split** on histopathology is the classic presentation of **Pemphigus vulgaris** - The flaccid (easily ruptured) nature of bullae distinguishes it from tense bullae seen in bullous pemphigoid - The suprabasal location of the split (just above the basal layer) with acantholysis (loss of cell-to-cell adhesion) is pathognomonic - **Statement 1 is CORRECT** ✓ **Analysis of Statement 2:** - The **"row of tombstones" or "tombstone appearance"** is indeed a diagnostic histopathological feature of Pemphigus vulgaris - This appearance results from basal keratinocytes remaining attached to the basement membrane while suprabasal cells separate due to acantholysis - The intact basal cells standing upright resemble a row of tombstones - **Statement 2 is CORRECT** ✓ **Does Statement 2 explain Statement 1?** - Statement 2 describes a **histopathological appearance** (tombstone pattern) that is a **consequence** of the suprabasal split - However, it does NOT explain the **underlying cause** of the flaccid bullae or the suprabasal split - The true explanation involves **IgG autoantibodies against desmoglein 3 (and desmoglein 1)**, which attack intercellular adhesion structures (desmosomes), causing **acantholysis** - Therefore, **Statement 2 does NOT explain Statement 1** ✗ *Incorrect: Statement 2 is the correct explanation for Statement 1* - While both statements describe features of Pemphigus vulgaris, the tombstone appearance is a descriptive finding, not an explanatory mechanism *Incorrect: Statements 1 and 2 are incorrect* - Both statements are medically accurate descriptions of Pemphigus vulgaris features *Incorrect: Statement 1 is incorrect* - Statement 1 correctly describes the cardinal clinical and histopathological features of Pemphigus vulgaris
Question 5: A 25-year-old female presents with the following lesions in the axilla, as shown by the arrow:
- A. Hidradenitis Suppurativa (Correct Answer)
- B. Acne fulminans
- C. Acne conglobata
- D. Fox-Fordyce disease
Explanation: ***Hidradenitis Suppurativa*** - This image displays typical features of Hidradenitis Suppurativa, including **inflamed nodules**, **abscesses**, and **sinus tracts** in the intertriginous region (axilla in this case). - The disease commonly affects areas with **apocrine glands** and is characterized by chronic inflammation and scarring. *Fox-Fordyce disease* - This condition involves an **obstruction of apocrine sweat ducts**, leading to pruritic papules in apocrine gland-bearing areas. - While it affects similar anatomical locations as hidradenitis suppurativa, it does not typically present with the same degree of inflammation, deep nodules, abscesses, or sinus tracts. *Acne fulminans* - This is a rare and severe form of **acne vulgaris** characterized by the sudden onset of aggressive, ulcerative, and extensively inflamed nodules, cysts, and plaques with systemic symptoms like fever and arthralgia. - It primarily affects the **face, chest, and back**, not typically the axilla, and is associated with systemic inflammation. *Acne conglobata* - A severe form of **nodulocystic acne** characterized by interconnected abscesses, cysts, and sinus tracts, often leaving significant scarring. - While it involves extensive inflammation and sinus tracts, it primarily affects the **trunk and face**, not characteristically the axilla as the primary site of presentation in images like this.
Question 6: What is the latest retinoid drug used in acne?
- A. Retinoic acid
- B. Clindamycin
- C. Adapalane (Correct Answer)
- D. Azelaic acid
Explanation: **Explanation:** **Adapalane** is the correct answer as it represents a **third-generation topical retinoid**. Unlike first-generation retinoids, adapalane is a naphthoic acid derivative that selectively binds to **Retinoic Acid Receptors (RAR-β and RAR-γ)**. This selectivity, combined with its lipophilic nature, allows it to penetrate the pilosebaceous unit more effectively while causing significantly less skin irritation (redness and peeling) compared to older agents like Tretinoin. It is currently the standard "latest" generation retinoid frequently tested in this context for its stability and improved safety profile. **Analysis of Incorrect Options:** * **Retinoic acid (Tretinoin):** This is a **first-generation** retinoid. While highly effective, it is more photolabile (degrades in sunlight) and generally more irritating to the skin than Adapalane. * **Clindamycin:** This is a **topical antibiotic**, not a retinoid. It acts by inhibiting protein synthesis in *Cutibacterium acnes* but does not possess the comedolytic properties of retinoids. * **Azelaic acid:** This is a dicarboxylic acid with antibacterial and antikeratinizing properties. While used in acne (especially for post-inflammatory hyperpigmentation), it is **not a retinoid**. **High-Yield Clinical Pearls for NEET-PG:** * **Generations of Retinoids:** * 1st: Tretinoin, Isotretinoin. * 2nd: Etretinate, Acitretin (used in Psoriasis). * 3rd: Adapalane, Tazarotene. * 4th: **Trifarotene** (The most recent, highly selective for RAR-γ). * **Mechanism:** Retinoids are **comedolytic**; they normalize follicular keratinization to prevent microcomedone formation. * **Teratogenicity:** All oral retinoids are strictly contraindicated in pregnancy (Category X). Isotretinoin requires a mandatory contraception period (1 month post-discontinuation).
Question 7: What are the treatment options for acne vulgaris?
- A. Dapsone
- B. Oral Minocycline
- C. Isotretinoin
- D. All the above (Correct Answer)
Explanation: **Explanation:** Acne vulgaris is a chronic inflammatory disease of the pilosebaceous unit. Its management is multifaceted, targeting the four key pathogenic factors: follicular hyperkeratinization, sebum production, *Cutibacterium acnes* colonization, and inflammation. * **Dapsone (Option A):** Topical dapsone (5% or 7.5% gel) is an effective treatment, particularly for inflammatory acne in adult females. It possesses potent anti-inflammatory properties. While oral dapsone is rarely used for routine acne due to side effects, it remains a recognized systemic option for severe, recalcitrant variants like Acne Fulminans. * **Oral Minocycline (Option B):** This is a second-generation tetracycline and a mainstay for moderate-to-severe inflammatory acne. It is highly lipophilic, ensuring excellent penetration into the pilosebaceous unit. It acts by inhibiting protein synthesis in *C. acnes* and reducing chemotactic factors. * **Isotretinoin (Option C):** This oral retinoid is the "gold standard" for severe nodulocystic acne. It is the only drug that addresses all four pathogenic mechanisms of acne. Since all three medications are established therapeutic options, **Option D (All the above)** is the correct answer. **Clinical Pearls for NEET-PG:** * **Isotretinoin:** Highly teratogenic (Category X); requires two forms of contraception and monthly pregnancy tests (IPLEDGE program). It can cause dryness (cheilitis is the most common side effect) and elevated triglycerides. * **Minocycline Side Effects:** Can cause blue-grey skin pigmentation, vestibular toxicity (vertigo), and drug-induced lupus. * **First-line for Mild Acne:** Topical retinoids (Adapalene) + Benzoyl Peroxide. * **Acne Fulminans:** The most severe form; treated with systemic steroids followed by low-dose Isotretinoin.
Question 8: An 18-year-old girl presents with predominantly comedonal acne. What is the first-line treatment?
- A. Topical retinoids (Correct Answer)
- B. Systemic retinoids
- C. Systemic antibiotics
- D. Topical steroids
Explanation: **Explanation:** The primary goal in treating acne is to target the specific pathogenic mechanism involved. In this case, the patient presents with **predominantly comedonal acne** (non-inflammatory lesions). **1. Why Topical Retinoids are correct:** Topical retinoids (e.g., Adapalene, Tretinoin) are the **first-line treatment** for comedonal acne because they are potent **comedolytic agents**. They work by normalizing follicular keratinization, which prevents the formation of the microcomedo (the precursor to all acne lesions). They also possess mild anti-inflammatory properties, making them the foundation of maintenance therapy. **2. Why other options are incorrect:** * **Systemic retinoids (Isotretinoin):** These are reserved for severe, nodulocystic, or scarring acne, or cases refractory to conventional therapy. They are too aggressive for simple comedonal acne. * **Systemic antibiotics:** These are indicated for moderate-to-severe *inflammatory* acne (papules/pustules) to target *C. acnes* colonization. They have no significant comedolytic activity. * **Topical steroids:** These are **contraindicated** in acne. In fact, prolonged use of topical steroids can induce "steroid-induced acne," characterized by monomorphic papulopustular eruptions. **Clinical Pearls for NEET-PG:** * **Adapalene** is often preferred over Tretinoin due to better photostability and less skin irritation. * **First-line for Mild Inflammatory Acne:** Topical Retinoid + Topical Antimicrobial (e.g., Benzoyl Peroxide or Clindamycin). * **Side Effects:** Topical retinoids commonly cause "retinoid dermatitis" (dryness, erythema, and scaling). Patients should be advised to apply them at night and use sunscreen.
Question 9: What causes a potato tumor?
- A. Hypertrophy of sweat glands of the nose
- B. Hypertrophy of sebaceous glands of the nose (Correct Answer)
- C. Hypotrophy of sweat glands of the nose
- D. All of the above
Explanation: **Explanation:** The term **"Potato Tumor"** is a clinical synonym for **Rhinophyma**, which represents the end-stage (Phymatous stage) of **Rosacea**. **1. Why Option B is Correct:** Rhinophyma is characterized by the progressive **hypertrophy and hyperplasia of the sebaceous glands** on the nose. This chronic inflammatory process leads to the deposition of fibrous tissue and an increase in connective tissue volume. Clinically, this results in a bulbous, irregular, and "potato-like" enlargement of the nose with prominent follicular pits. It is most commonly seen in elderly males. **2. Why Other Options are Incorrect:** * **Option A & C:** Rhinophyma specifically involves the pilosebaceous unit (sebaceous glands), not the eccrine or apocrine sweat glands. While the nose contains sweat glands, they do not undergo the massive hypertrophy required to produce a phymatous change. * **Option D:** Since the pathology is specific to sebaceous gland hypertrophy, "All of the above" is incorrect. **Clinical Pearls for NEET-PG:** * **Rosacea Stages:** Erythematotelangiectatic (flushing), Papulopustular, Phymatous (Rhinophyma), and Ocular rosacea. * **Demographics:** While Rosacea is more common in females, **Rhinophyma is significantly more common in males** (Male:Female ratio approx. 20:1). * **Misconception:** Historically, rhinophyma was falsely linked to chronic alcoholism ("rum nose"); however, alcohol is merely a trigger for flushing, not the primary cause. * **Treatment:** Early stages are treated with topical metronidazole or oral isotretinoin. Advanced Rhinophyma (Potato Tumor) usually requires **surgical intervention** (CO2 laser or dermabrasion) to reshape the nose.
Question 10: A teenage girl presented in OPD with moderate acne and history of irregular menses. What treatment will you give?
- A. Oral isotretinoin
- B. Oral acitretin
- C. Oral minocycline
- D. Cyproterone acetate (Correct Answer)
Explanation: ### Explanation **Concept:** The clinical presentation of **moderate acne** associated with **irregular menses** in a teenage girl strongly suggests an underlying hormonal imbalance, most commonly **Polycystic Ovary Syndrome (PCOS)**. In such cases, the acne is driven by hyperandrogenism. **Cyproterone acetate** is a potent anti-androgen that works by blocking androgen receptors and inhibiting 5-alpha reductase. When combined with ethinylestradiol (as an oral contraceptive pill), it regulates the menstrual cycle while effectively treating hormonal acne. **Analysis of Options:** * **Cyproterone acetate (Correct):** It addresses the root cause (hyperandrogenism) in patients with menstrual irregularities. It is the treatment of choice for female patients with adult-onset acne or acne associated with signs of virilization/PCOS. * **Oral isotretinoin:** Reserved for severe, nodulocystic, or scarring acne. While effective, it does not address the underlying hormonal trigger in this specific scenario. * **Oral acitretin:** This is a second-generation retinoid used primarily for **psoriasis** (especially palmoplantar and pustular types). It is contraindicated in women of childbearing age due to its long half-life and extreme teratogenicity. * **Oral minocycline:** An antibiotic used for inflammatory acne. It provides symptomatic relief but does not correct the hormonal dysfunction causing the irregular menses. **Clinical Pearls for NEET-PG:** * **SAHA Syndrome:** Seborrhea, Acne, Hirsutism, and Alopecia; often seen in hormonal acne. * **Spironolactone:** Another anti-androgen used off-label for female acne, but Cyproterone acetate is the classic answer when menstrual regulation is also required. * **First-line for Moderate Acne (General):** Usually a combination of topical retinoids and topical/oral antibiotics. However, the presence of "irregular menses" shifts the focus to **hormonal therapy**.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free